A Narrative Review of COVID-19 Vaccines

The COVID-19 pandemic has shaken the world since early 2020 and its health, social, economic, and societal negative impacts at the global scale have been catastrophic. Since the early days of the pandemic, development of safe and effective vaccines was judged to be the best possible tool to minimize...

Full description

Saved in:
Bibliographic Details
Published in:Vaccines (Basel) 2021-12, Vol.10 (1), p.62
Main Authors: Eroglu, Barbaros, Nuwarda, Rina Fajri, Ramzan, Iqbal, Kayser, Veysel
Format: Article
Language:English
Subjects:
Coronaviruses
COVID-19
COVID-19 vaccines
Disease transmission
Epidemics
Genomes
Infections
Jurisdiction
Medical research
Middle East respiratory syndrome
Mortality
Mutation
Pandemics
Peptides
Pneumonia
Proteins
Public health
Respiratory diseases
Review
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
vaccination
vaccine hesitancy
Vaccines
Viral diseases
Viruses
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The COVID-19 pandemic has shaken the world since early 2020 and its health, social, economic, and societal negative impacts at the global scale have been catastrophic. Since the early days of the pandemic, development of safe and effective vaccines was judged to be the best possible tool to minimize the effects of this pandemic. Drastic public health measures were put into place to stop the spread of the virus, with the hope that vaccines would be available soon. Thanks to the extraordinary commitments of many organizations and individuals from around the globe and the collaborative effort of many international scientists, vaccines against COVID-19 received regulatory approval for emergency human use in many jurisdictions in less than a year after the identification of the viral sequence. Several of these vaccines have been in use for some time; however, the pandemic is still ongoing and likely to persist for the foreseeable future. This is due to many reasons including reduced compliance with public health restrictions, limited vaccine manufacturing/distribution capacity, high rates of vaccine hesitancy, and the emergence of new variants with the capacity to spread more easily and to evade current vaccines. Here we discuss the discovery and availability of COVID-19 vaccines and evolving issues around mass vaccination programs.
ISSN:2076-393X
2076-393X
DOI:10.3390/vaccines10010062